AstraZeneca to take another shot at delisting Indian arm
This article was originally published in Scrip
Executive Summary
Shares of AstraZeneca Pharma India surged on local bourses after it said that parent company AstraZeneca Pharmaceuticals AB Sweden plans to take another shot at delisting the firm.